Baxter Collaborates with Cosmed to Commercialize Q-NRG+ Indirect Calorimetry Device to Support Global Clinical Nutrition 

 Baxter Collaborates with Cosmed to Commercialize Q-NRG+ Indirect Calorimetry Device to Support Global Clinical Nutrition 

Baxter Collaborates with Cosmed to Commercialize Q-NRG+ Indirect Calorimetry Device to Support Global Clinical Nutrition

Shots:

  • Baxter will commercialize Q-NRG+ in 18 countries around the globe with its expected availability in Sept’19 as a part of its launch in selected EU countries, Canada and Australia with the potential for further expansion in other markets
  • Baxter’s Q-NRG+ utilized indirect calorimetry (IC) technology to measure patient’s calorie need at rest (resting energy expenditure, REE) to optimize nutrition therapy improving the patients’ outcomes
  • Q-NRG+ is a flexible & portable device which requires minimal warm-up and calibration time and can accurately measure patient’s REE and helps physician/clinicians to regularly re-assess energy needs and adjust clinical nutrition prescriptions as required

Click here to­ read full press release/ article | Ref: Baxter | Image: Baxter

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post